Home>Topics>Companies>Ranbaxy Laboratories

Ranbaxy Laboratories

  1. All
  2. Commentary
  3. Headlines
  1. Europe's regulator to inspect Ranbaxy's India plant in June

    Headlines

    Wed, 9 Apr 2014

    MUMBAI, April 9 (Reuters) - Europe's drug regulator said on Wednesday an inspection of Indian generic drugmaker Ranbaxy Laboratories Ltd 's Dewas plant in India is planned for June, amid concerns about its production processes after a spate of regulatory sanctions.

  2. UPDATE 2-India regulator examines Sun, Ranbaxy merger trading - source

    Headlines

    Wed, 9 Apr 2014

    * SEBI to ask Sun Pharma, Ranbaxy for information on merger

  3. India's Sun Pharma plans gradual phase-out of Ranbaxy -branded drugs in U.S.: sources

    Headlines

    Wed, 9 Apr 2014

    Reuters) - India's Sun Pharmaceutical Industries Ltd plans to begin phasing out sales of generic drugs branded as Ranbaxy Laboratories Ltd products in the United States, after completing a $3.2 billion takeover of its loss-making rival by the

  4. UPDATE 2-India's Sun Pharma plans gradual phase-out of Ranbaxy -branded drugs in US -sources

    Headlines

    Wed, 9 Apr 2014

    * European regulator plans Ranbaxy plant inspection in June (Adds fund manager comment, European regulator comments)

  5. India's Sun Pharma plans gradual phase-out of Ranbaxy -branded drugs in US -sources

    Headlines

    Wed, 9 Apr 2014

    Reuters) - India's Sun Pharmaceutical Industries Ltd plans to begin phasing out sales of generic drugs branded as Ranbaxy Laboratories Ltd products in the United States after completing a $3.2 billion takeover of its loss-making rival, sources

  6. Indian brokers association to ask regulator to investigate Ranbaxy trades

    Headlines

    Wed, 9 Apr 2014

    brokerage association plans to formally ask the domestic market regulator to investigate trading in drugmaker Ranbaxy Laboratories Ltd 's shares in the days leading up to the announcement that it will be acquired by rival Sun Pharmaceutical Industries

  7. Update-Moody's: Daiichi Sankyo Will Benefit from Sun Pharma's Acquisition of Ranbaxy

    Headlines

    Wed, 9 Apr 2014

    Sun Pharmaceutical Industries Ltd (Sun Pharma) & Ranbaxy Laboratories Ltd ( Ranbaxy )

  8. INDIA PRESS-Sun Pharma- Ranbaxy deal may come under Sebi lens-Business Standard

    Headlines

    Tue, 8 Apr 2014

    Note: Reuters has not verified this story and does not vouch for its accuracy. (Compiled by Abhiram Nandakumar in Bangalore)

  9. Sun buys Ranbaxy

    Headlines

    Mon, 7 Apr 2014

    India's Sun Pharmaceuticals gobbles up scandal-plagued Ranbaxy Laboratories for $3.2B. The acquisition makes Sun the fifth largest generic drugs firm in the world with combined revenues of $4.2B and

  10. India's Sun Pharma to buy struggling Ranbaxy for $3.2 billion as Daiichi Sankyo retreats

    Headlines

    Mon, 7 Apr 2014

    Industries Ltd has agreed to buy generic drugmaker Ranbaxy Laboratories Ltd for $3.2 billion, betting it can fix factory ..... that plagued the current owner, Japan's Daiichi Sankyo Co , and got Ranbaxy India-made drugs barred from the United

« Prev12345Next »
Content Partners